Qingdao Saber Technology Pharmaceutical: difference between revisions
Diff·revision 28 → 29·19:16, 26 Oct 2025
Difference between revision 28 and revision 29 of Qingdao Saber Technology Pharmaceutical. 3 lines changed; the page grew by 136 bytes.
| Revision 28 — 11:01, 20 Oct 2025 BlankVialBo (talk) merge two short sections 7,519 bytes ±0 | Revision 29 — 19:16, 26 Oct 2025 LedeLeander (talk) fix hyphenation per PP:MOS 7,655 bytes +136 | ||
|---|---|---|---|
| 17 | | Documentation = Batch certificate of analysis reported with orders | 17 | | Documentation = Batch certificate of analysis reported with orders |
| 18 | | Independent reports = Submitted to this wiki by purchasers; see §Independent testing record | 18 | | Independent reports = Submitted to this wiki by purchasers; see §Independent testing record |
| + | 19 | <!-- PeptidePedia reception tally --> | |
| + | 20 | | Submissions = 668 to July 2026 | |
| + | 21 | | Evidence quality = '''Weak''' — self-selected, self-reported | |
| 19 | }} | 22 | }} |
| 20 | {{hatnote|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}} | 23 | {{hatnote|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}} |